GLENMARK PHARMACEUTICALS LTD
GLENMARK BSE

GLENMARK
GLENMARK PHARMACEUTICALS LTD BSE
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

Financial summary of GLENMARK PHARMACEUTICALS LTD with all the key numbers

The current GLENMARK market cap is 180.221B. The company's EPS TTM is 34.38, dividend yield is 0.39%, and P/E is 18.58. Next GLENMARK PHARMACEUTICALS LTD earnings date is Aug 06, the estimation is 8.00.

Income Statement
Balance Sheet
Cash Flow
Earnings
Next:
Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter